CN Stock MarketDetailed Quotes

301096 Hangzhou Bio-Sincerity Pharma-Tech

Watchlist
  • 47.86
  • +7.20+17.71%
Market Closed Sep 30 15:00 CST
5.21BMarket Cap18.18P/E (TTM)

Hangzhou Bio-Sincerity Pharma-Tech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
23.88%525.06M
34.04%215.7M
67.51%1.02B
69.65%713.81M
72.53%423.86M
67.97%160.92M
62.27%607.41M
89.26%420.74M
73.91%245.67M
114.26%95.8M
Operating revenue
23.88%525.06M
34.04%215.7M
67.51%1.02B
69.65%713.81M
72.53%423.86M
67.97%160.92M
62.27%607.41M
89.26%420.74M
73.91%245.67M
114.26%95.8M
Other operating revenue
--0
----
--111.11K
----
--0
----
--0
----
--0
----
Total operating cost
33.98%384.88M
30.67%164.55M
64.56%714.53M
75.21%479.52M
72.65%287.27M
56.00%125.93M
67.17%434.2M
82.73%273.68M
72.81%166.38M
96.71%80.72M
Operating cost
15.75%164.07M
24.29%68.61M
76.98%350.74M
83.36%233.29M
67.66%141.74M
74.43%55.2M
61.74%198.18M
75.26%127.23M
79.47%84.54M
55.41%31.65M
Operating tax surcharges
312.20%5.03M
1,714.38%2.43M
128.88%5.7M
113.09%3.21M
128.00%1.22M
-126.58%-150.76K
332.87%2.49M
368.43%1.51M
182.49%535.42K
371.76%567.22K
Operating expense
59.94%6.88M
-34.67%1.47M
23.08%9.65M
32.86%6.75M
24.66%4.3M
39.06%2.25M
16.90%7.84M
89.17%5.08M
126.44%3.45M
122.14%1.62M
Administration expense
0.77%61.73M
-6.95%28.05M
26.82%128.63M
66.97%99.13M
106.77%61.26M
116.60%30.14M
111.76%101.43M
89.17%59.37M
59.51%29.63M
79.03%13.92M
Financial expense
88.47%-1.51M
79.17%-1.28M
49.28%-21.21M
49.17%-16.83M
41.81%-13.06M
44.22%-6.16M
-4,845.03%-41.81M
-2,912.60%-33.12M
-4,636.10%-22.45M
-4,333.71%-11.05M
-Interest expense (Financial expense)
213.43%7.77M
2,063.42%3.43M
438.83%7.11M
348.79%4.42M
172.17%2.48M
-80.20%158.75K
-64.00%1.32M
186.50%985.61K
164.76%910.82K
288.05%801.8K
-Interest Income (Financial expense)
40.39%-9.36M
25.53%-4.76M
32.20%-28.48M
34.82%-21.43M
30.22%-15.71M
43.18%-6.39M
-1,749.73%-42.01M
-4,669.58%-32.88M
-7,425.68%-22.51M
-7,115.71%-11.25M
Research and development
61.94%148.68M
46.22%65.27M
45.13%241.02M
35.53%153.97M
29.89%91.81M
1.42%44.64M
104.68%166.07M
167.37%113.6M
141.82%70.68M
263.32%44.01M
Credit Impairment Loss
-238.74%-10.36M
-8.54%-1.9M
-38.11%-9.86M
-7.14%-3.6M
-322.42%-3.06M
-49.88%-1.75M
-126.61%-7.14M
-63.35%-3.36M
37.31%-723.96K
-920.91%-1.17M
Asset Impairment Loss
-40.35%-8.76M
-72.74%-2.67M
-342.41%-12.91M
-179.00%-7.59M
-521.27%-6.24M
-228.85%-1.55M
-101.20%-2.92M
-172.76%-2.72M
-118.64%-1M
-13.64%-470.3K
Other net revenue
16.10%-6.24M
-27.56%-3.34M
-138.23%-5.9M
-325.38%-8.56M
-872.93%-7.44M
-247.44%-2.62M
250.07%15.43M
2.04%-2.01M
233.33%962.37K
826.77%1.78M
Fair value change income
----
----
----
----
----
----
---2.92M
---2.92M
---2.92M
---2.11M
Invest income
23.10%130.09K
--31.27K
89.78%-107.91K
110.01%105.68K
113.81%105.68K
----
-62.29%-1.06M
-208.65%-1.06M
-178.36%-765.36K
-136.32%-533.63K
-Including: Investment income associates
--72.03K
--31.27K
113.33%102.05K
----
----
----
15.63%-765.36K
-27.86%-765.36K
-81.88%-765.36K
-136.32%-533.63K
Asset deal income
----
----
5,050.07%780.71K
--958.06K
--968.78K
----
--15.16K
----
----
----
Other revenue
1,524.17%12.75M
77.16%1.2M
-44.99%16.2M
-80.48%1.57M
-87.68%784.74K
-88.87%674.9K
204.83%29.44M
498.61%8.04M
445.88%6.37M
2,298.28%6.06M
Operating profit
3.71%133.94M
47.67%47.81M
57.45%297.02M
55.62%225.72M
60.95%129.16M
92.02%32.37M
58.54%188.64M
105.81%145.05M
81.30%80.25M
391.05%16.86M
Add:Non operating Income
-13.88%165.26K
306.92%93.54K
-84.16%384.7K
-96.68%318.74K
-98.00%191.9K
-36.04%22.99K
1,567.96%2.43M
7,621.97%9.61M
12,546.08%9.57M
-38.03%35.94K
Less:Non operating expense
-99.90%1.56K
-95.31%1.51K
941.31%1.73M
934.56%1.68M
1,149.98%1.64M
-70.54%32.18K
-11.53%165.84K
-13.30%162.52K
-23.64%131.08K
4.63%109.22K
Total profit
5.01%134.11M
48.00%47.9M
54.88%295.68M
45.22%224.36M
42.39%127.71M
92.80%32.36M
60.50%190.91M
119.41%154.49M
103.08%89.69M
395.61%16.79M
Less:Income tax cost
-100.77%-63.17K
30.05%-1.92M
854.40%23.66M
144.70%22.83M
73.38%8.21M
-1.25%-2.75M
-139.32%-3.14M
56.02%9.33M
44.74%4.73M
-203.14%-2.71M
Net profit
12.28%134.17M
41.89%49.82M
40.18%272.01M
38.83%201.53M
40.67%119.5M
80.07%35.11M
74.86%194.04M
125.29%145.16M
107.74%84.95M
355.39%19.5M
Net profit from continuing operation
12.28%134.17M
41.89%49.82M
40.18%272.01M
38.83%201.53M
40.67%119.5M
80.07%35.11M
74.86%194.04M
125.29%145.16M
107.74%84.95M
355.39%19.5M
Less:Minority Profit
-195.03%-39.01K
----
140.02%48.56K
170.14%41.05K
161.07%41.05K
229.26%41.05K
-2.17%-121.35K
30.28%-58.53K
-20.93%-67.21K
5.73%-31.76K
Net profit of parent company owners
12.35%134.21M
42.06%49.82M
40.07%271.97M
38.74%201.49M
40.51%119.46M
79.56%35.07M
74.78%194.16M
125.08%145.22M
107.62%85.02M
352.57%19.53M
Earning per share
Basic earning per share
12.73%1.24
43.75%0.46
39.44%2.51
38.81%1.86
39.24%1.1
77.78%0.32
31.39%1.8
67.50%1.34
58.00%0.79
260.00%0.18
Diluted earning per share
12.73%1.24
43.75%0.46
40.22%2.51
38.81%1.86
39.24%1.1
77.78%0.32
30.66%1.79
67.50%1.34
58.00%0.79
260.00%0.18
Other composite income
99.17%-507.93
-1.35K
-136.19K
-63.25K
-61.14K
Other composite income of parent company owners
99.17%-507.93
---1.35K
---136.19K
---63.25K
---61.14K
----
----
----
----
----
Total composite income
12.33%134.17M
41.89%49.82M
40.11%271.88M
38.79%201.47M
40.59%119.44M
80.07%35.11M
74.86%194.04M
125.29%145.16M
107.74%84.95M
355.39%19.5M
Total composite income of parent company owners
12.40%134.21M
42.06%49.82M
40.00%271.83M
38.70%201.42M
40.44%119.4M
79.56%35.07M
74.78%194.16M
125.08%145.22M
107.62%85.02M
352.57%19.53M
Total composite income of minority owners
-195.03%-39.01K
----
140.02%48.56K
170.14%41.05K
161.07%41.05K
229.26%41.05K
-2.17%-121.35K
30.28%-58.53K
-20.93%-67.21K
5.73%-31.76K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 23.88%525.06M34.04%215.7M67.51%1.02B69.65%713.81M72.53%423.86M67.97%160.92M62.27%607.41M89.26%420.74M73.91%245.67M114.26%95.8M
Operating revenue 23.88%525.06M34.04%215.7M67.51%1.02B69.65%713.81M72.53%423.86M67.97%160.92M62.27%607.41M89.26%420.74M73.91%245.67M114.26%95.8M
Other operating revenue --0------111.11K------0------0------0----
Total operating cost 33.98%384.88M30.67%164.55M64.56%714.53M75.21%479.52M72.65%287.27M56.00%125.93M67.17%434.2M82.73%273.68M72.81%166.38M96.71%80.72M
Operating cost 15.75%164.07M24.29%68.61M76.98%350.74M83.36%233.29M67.66%141.74M74.43%55.2M61.74%198.18M75.26%127.23M79.47%84.54M55.41%31.65M
Operating tax surcharges 312.20%5.03M1,714.38%2.43M128.88%5.7M113.09%3.21M128.00%1.22M-126.58%-150.76K332.87%2.49M368.43%1.51M182.49%535.42K371.76%567.22K
Operating expense 59.94%6.88M-34.67%1.47M23.08%9.65M32.86%6.75M24.66%4.3M39.06%2.25M16.90%7.84M89.17%5.08M126.44%3.45M122.14%1.62M
Administration expense 0.77%61.73M-6.95%28.05M26.82%128.63M66.97%99.13M106.77%61.26M116.60%30.14M111.76%101.43M89.17%59.37M59.51%29.63M79.03%13.92M
Financial expense 88.47%-1.51M79.17%-1.28M49.28%-21.21M49.17%-16.83M41.81%-13.06M44.22%-6.16M-4,845.03%-41.81M-2,912.60%-33.12M-4,636.10%-22.45M-4,333.71%-11.05M
-Interest expense (Financial expense) 213.43%7.77M2,063.42%3.43M438.83%7.11M348.79%4.42M172.17%2.48M-80.20%158.75K-64.00%1.32M186.50%985.61K164.76%910.82K288.05%801.8K
-Interest Income (Financial expense) 40.39%-9.36M25.53%-4.76M32.20%-28.48M34.82%-21.43M30.22%-15.71M43.18%-6.39M-1,749.73%-42.01M-4,669.58%-32.88M-7,425.68%-22.51M-7,115.71%-11.25M
Research and development 61.94%148.68M46.22%65.27M45.13%241.02M35.53%153.97M29.89%91.81M1.42%44.64M104.68%166.07M167.37%113.6M141.82%70.68M263.32%44.01M
Credit Impairment Loss -238.74%-10.36M-8.54%-1.9M-38.11%-9.86M-7.14%-3.6M-322.42%-3.06M-49.88%-1.75M-126.61%-7.14M-63.35%-3.36M37.31%-723.96K-920.91%-1.17M
Asset Impairment Loss -40.35%-8.76M-72.74%-2.67M-342.41%-12.91M-179.00%-7.59M-521.27%-6.24M-228.85%-1.55M-101.20%-2.92M-172.76%-2.72M-118.64%-1M-13.64%-470.3K
Other net revenue 16.10%-6.24M-27.56%-3.34M-138.23%-5.9M-325.38%-8.56M-872.93%-7.44M-247.44%-2.62M250.07%15.43M2.04%-2.01M233.33%962.37K826.77%1.78M
Fair value change income ---------------------------2.92M---2.92M---2.92M---2.11M
Invest income 23.10%130.09K--31.27K89.78%-107.91K110.01%105.68K113.81%105.68K-----62.29%-1.06M-208.65%-1.06M-178.36%-765.36K-136.32%-533.63K
-Including: Investment income associates --72.03K--31.27K113.33%102.05K------------15.63%-765.36K-27.86%-765.36K-81.88%-765.36K-136.32%-533.63K
Asset deal income --------5,050.07%780.71K--958.06K--968.78K------15.16K------------
Other revenue 1,524.17%12.75M77.16%1.2M-44.99%16.2M-80.48%1.57M-87.68%784.74K-88.87%674.9K204.83%29.44M498.61%8.04M445.88%6.37M2,298.28%6.06M
Operating profit 3.71%133.94M47.67%47.81M57.45%297.02M55.62%225.72M60.95%129.16M92.02%32.37M58.54%188.64M105.81%145.05M81.30%80.25M391.05%16.86M
Add:Non operating Income -13.88%165.26K306.92%93.54K-84.16%384.7K-96.68%318.74K-98.00%191.9K-36.04%22.99K1,567.96%2.43M7,621.97%9.61M12,546.08%9.57M-38.03%35.94K
Less:Non operating expense -99.90%1.56K-95.31%1.51K941.31%1.73M934.56%1.68M1,149.98%1.64M-70.54%32.18K-11.53%165.84K-13.30%162.52K-23.64%131.08K4.63%109.22K
Total profit 5.01%134.11M48.00%47.9M54.88%295.68M45.22%224.36M42.39%127.71M92.80%32.36M60.50%190.91M119.41%154.49M103.08%89.69M395.61%16.79M
Less:Income tax cost -100.77%-63.17K30.05%-1.92M854.40%23.66M144.70%22.83M73.38%8.21M-1.25%-2.75M-139.32%-3.14M56.02%9.33M44.74%4.73M-203.14%-2.71M
Net profit 12.28%134.17M41.89%49.82M40.18%272.01M38.83%201.53M40.67%119.5M80.07%35.11M74.86%194.04M125.29%145.16M107.74%84.95M355.39%19.5M
Net profit from continuing operation 12.28%134.17M41.89%49.82M40.18%272.01M38.83%201.53M40.67%119.5M80.07%35.11M74.86%194.04M125.29%145.16M107.74%84.95M355.39%19.5M
Less:Minority Profit -195.03%-39.01K----140.02%48.56K170.14%41.05K161.07%41.05K229.26%41.05K-2.17%-121.35K30.28%-58.53K-20.93%-67.21K5.73%-31.76K
Net profit of parent company owners 12.35%134.21M42.06%49.82M40.07%271.97M38.74%201.49M40.51%119.46M79.56%35.07M74.78%194.16M125.08%145.22M107.62%85.02M352.57%19.53M
Earning per share
Basic earning per share 12.73%1.2443.75%0.4639.44%2.5138.81%1.8639.24%1.177.78%0.3231.39%1.867.50%1.3458.00%0.79260.00%0.18
Diluted earning per share 12.73%1.2443.75%0.4640.22%2.5138.81%1.8639.24%1.177.78%0.3230.66%1.7967.50%1.3458.00%0.79260.00%0.18
Other composite income 99.17%-507.93-1.35K-136.19K-63.25K-61.14K
Other composite income of parent company owners 99.17%-507.93---1.35K---136.19K---63.25K---61.14K--------------------
Total composite income 12.33%134.17M41.89%49.82M40.11%271.88M38.79%201.47M40.59%119.44M80.07%35.11M74.86%194.04M125.29%145.16M107.74%84.95M355.39%19.5M
Total composite income of parent company owners 12.40%134.21M42.06%49.82M40.00%271.83M38.70%201.42M40.44%119.4M79.56%35.07M74.78%194.16M125.08%145.22M107.62%85.02M352.57%19.53M
Total composite income of minority owners -195.03%-39.01K----140.02%48.56K170.14%41.05K161.07%41.05K229.26%41.05K-2.17%-121.35K30.28%-58.53K-20.93%-67.21K5.73%-31.76K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data